References

Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association.

10.1161/cir.0000000000001184 · 2023 · External reference

Global burden of the key components of cardiovascular-kidney-metabolic syndrome.

10.1681/asn.0000000658 · 2025 · External reference

Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999–2020.

10.1001/jamacardio.2023.3241 · 2023 · External reference

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association.

10.1161/cir.0000000000001186 · 2023 · External reference

Inflammation in cardiovascular-kidney-metabolic syndrome: key roles and underlying mechanisms-a comprehensive review.

10.1007/s11010-025-05379-9 · 2025 · External reference

Humanistic and economic burden of patients with cardiorenal metabolic conditions: a systematic review.

10.1007/s13300-023-01464-8 · 2023 · External reference

Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: a presidential advisory from the American Heart Association.

10.1161/cir.0000000000001258 · 2024 · External reference

Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011–2020.

10.1001/jama.2024.6892 · 2024 · External reference

Associations of cardiovascular-kidney-metabolic syndrome with premature mortality and life expectancies in US adults: a cohort study.

10.1159/000546618 · 2025 · External reference

Using the American Heart Association’s new “cardiovascular-kidney-metabolic syndrome” metrics to assess life expectancy in us adults: a life table analysis.

10.1016/j.ajpc.2025.101339 · 2025 · External reference

Antioxidant and anti-inflammatory potential of polyphenols contained in mediterranean diet in obesity: molecular mechanisms.

10.3390/molecules26040985 · 2021 · External reference

Nelumbinis plumula attenuates high-fat-induced inflammation in non-alcoholic fatty liver through the NOX/NF-κB pathway.

10.1016/j.jep.2025.120663 · 2026 · External reference

Proanthocyanidins from Iris lactea Pall. var. chinensis (Fisch.) Koidz alleviate non-alcoholic fatty liver disease by regulating lipid metabolism via AMPK/SREBP-1c signalling pathway.

10.1016/j.jep.2025.120784 · 2026 · External reference

Antioxidant flavonols and coronary heart disease risk.

10.1016/s0140-6736(05)60135-3 · 1997 · External reference

A greater flavonoid intake is associated with lower total and cause-specific mortality: a meta-analysis of cohort studies.

10.3390/nu12082350 · 2020 · External reference

Association of dietary flavonoids intake with all-cause and cardiovascular disease mortality in diabetic kidney disease: a cohort study from the NHANES database.

10.1155/2024/8359294 · 2024 · External reference

High diversity of dietary flavonoid intake is associated with a lower risk of all-cause mortality and major chronic diseases.

10.1038/s43016-025-01176-1 · 2025 · External reference

Flavan-3-ols and cardiometabolic health: first ever dietary bioactive guideline.

10.1093/advances/nmac105 · 2022 · External reference

Dietary intake of polyphenols and all-cause mortality: a systematic review with meta-analysis.

10.3390/metabo14080404 · 2024 · External reference

Total dietary flavonoid intake and risk of cardiometabolic diseases: a dose-response meta-analysis of prospective cohort studies.

10.1080/10408398.2022.2126427 · 2024 · External reference

Anthocyanins-gut microbiota-health axis: a review.

10.1080/10408398.2023.2187212 · 2024 · External reference

Combined nutraceutical approach to postmenopausal syndrome and vascular remodeling biomarkers.

10.1089/acm.2011.0624 · 2013 · External reference

Effects of soy isoflavones on serum systemic and vascular inflammation markers and oxidative stress in peritoneal dialysis patients: a randomized controlled trial.

10.1002/ptr.6729 · 2020 · External reference

Dietary total flavonoids intake and risk of mortality from all causes and cardiovascular disease in the general population: a systematic review and meta‐analysis of cohort studies.

10.1002/mnfr.201601003 · 2017 · External reference

Flavonoid intake is associated with lower mortality in the Danish Diet Cancer and Health Cohort.

10.1038/s41467-019-11622-x · 2019 · External reference

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

10.1016/j.jclinepi.2007.11.008 · 2008 · External reference

Social risk profile and cardiovascular-kidney-metabolic syndrome in US adults.

10.1161/jaha.124.034996 · 2024 · External reference

Sex differences in cardiovascular-kidney-metabolic syndrome: 30-year US trends and mortality risks-brief report.

10.1161/atvbaha.124.321629 · 2025 · External reference

Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association.

10.1161/cir.0000000000001191 · 2023 · External reference

The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.

10.1038/ki.2010.483 · 2011 · External reference

Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health.

10.1001/jamanetworkopen.2024.45309 · 2024 · External reference

Dietary polyphenol intake in US adults and 10-year trends: 2007-2016.

10.1016/j.jand.2020.06.016 · 2020 · External reference

Association of dietary flavonoid intakes with prevalence of chronic respiratory diseases in adults.

10.1186/s12967-024-04949-7 · 2024 · External reference

Simulation study of confounder-selection strategies.

10.1093/oxfordjournals.aje.a116813 · 1993 · External reference

Assessing proportionality in the proportional odds model for ordinal logistic regression.

10.2307/2532457 · 1990 · External reference

A quantile-based g-computation approach to addressing the effects of exposure mixtures.

10.1289/ehp5838 · 2020 · External reference

A review of practical statistical methods used in epidemiological studies to estimate the health effects of multi-pollutant mixture.

10.1016/j.envpol.2022.119356 · 2022 · External reference

Adjustment for total energy intake in epidemiologic studies.

10.1093/ajcn/65.4.1220s · 1997 · External reference

Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements.

10.1093/oxfordjournals.aje.a009849 · 1999 · External reference

Adjustment for energy intake in nutritional research: a causal inference perspective.

10.1093/ajcn/nqab266 · 2022 · External reference

Practical recommendations for reporting Fine–Gray model analyses for competing risk data.

10.1002/sim.7501 · 2017 · External reference

Role of oxidative balance score in staging and mortality risk of cardiovascular-kidney-metabolic syndrome: insights from traditional and machine learning approaches.

10.1016/j.redox.2025.103588 · 2025 · External reference

Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults.

10.3945/ajcn.111.016634 · 2012 · External reference

Protective dietary antioxidants intake attenuate cardiovascular-kidney-metabolic syndrome progression.

2025 · External reference

Berry anthocyanin intake and cardiovascular health.

10.1016/j.mam.2017.05.002 · 2018 · External reference

Characterization of antioxidant polyphenols from Myrciaria jaboticaba peel and their effects on glucose metabolism and antioxidant status: a pilot clinical study.

10.1016/j.foodchem.2016.04.142 · 2016 · External reference

Dietary intake of anthocyanins and risk of cardiovascular disease: a systematic review and meta-analysis of prospective cohort studies.

10.1080/10408398.2018.1509835 · 2019 · External reference

Anthocyanins-rich interventions on oxidative stress, inflammation and lipid profile in patients undergoing hemodialysis: meta-analysis and meta-regression.

10.1038/s41430-022-01175-6 · 2023 · External reference

Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women.

10.1093/jn/134.3.574 · 2004 · External reference

Flavonoid subclasses and type 2 diabetes mellitus risk: a meta-analysis of prospective cohort studies.

10.1080/10408398.2018.1476964 · 2019 · External reference

Isoflavones obtained from red clover improve both dyslipidemia and menopausal symptoms in menopausal women: a prospective randomized placebo-controlled trial.

10.1080/13697137.2024.2393121 · 2024 · External reference

Potential effects of bioactive compounds of plant-based foods and medicinal plants in chronic kidney disease and dialysis: a systematic review.

10.3390/nu16244321 · 2024 · External reference

Systematic bioinformatic analysis of nutrigenomic data of flavanols in cell models of cardiometabolic disease.

10.1039/d0fo00701c · 2020 · External reference

Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies.

10.1136/bmj.n604 · 2021 · External reference

Peripheral neuropathy and all-cause and cardiovascular mortality in U.S. adults : a prospective cohort study.

10.7326/m20-1340 · 2021 · External reference

Associations of serum carotenoids with risk of cardiovascular mortality among individuals with type 2 diabetes: results from NHANES.

10.2337/dc21-2371 · 2022 · External reference